WinstonWınston
Back
PT Industri Jamu dan Farmasi Sido Muncul Tbk logo

PT Industri Jamu dan Farmasi Sido Muncul Tbk

SIDO.JK
69
Drug Manufacturers - Specialty & Generic · Healthcare
Price
350.00 IDR
+0.00 (+0.00%)
Market Cap
10.30T IDR
Exchange
Indonesia Stock Exchange
Winston Score
69
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 24, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Mixed
Cash Flow
Exceptional
Stability
Exceptional
Valuation
Good
Dividends
Exceptional

Winston Score History

The full picture

PT Industri Jamu dan Farmasi Sido Muncul Tbk is an Indonesian enterprise specializing in the production and distribution of herbal remedies, cosmetics, and health-focused food and beverage items. Its operations are divided into three primary segments: Herbal Medicine and Supplements, Food and Beverage, and Pharmacy. The company offers a comprehensive range of both ethical (prescription) and over-the-counter products, addressing a vast array of health concerns such as pain management, immune system support, cardiovascular health, digestive wellness, skin conditions, and various other specific ailments. Beyond its core activities, Sido Muncul also engages in commercial ventures, land transportation, wastewater treatment, plantation management, and printing services. Established in 1940, the company is headquartered in Semarang, Indonesia, and operates as a subsidiary of PT Hotel Candi Baru.

Share count broadly stable

0.4% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 29.83B (2021) → 29.72B (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
50.0%
Healthy — 50.0% gross margin
Profit after running costs
Operating Margin
26.2%
Excellent — 26.2% operating margin
Return on the money invested
ROCE
39.6%
Exceptional — 39.6% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-3.5%
Shrinking sales (-3.5% YoY)
Profit growth
EPS YoY
-15.8%
Earnings shrinking (-15.8% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
112%
Turns 112% of profit into real cash
Spare cash per sale
FCF Margin
27.4%
Converts sales into free cash efficiently (27.4%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.00
Conservative — low debt load (0.00)
Covers its interest
Interest Cover
2864.07x
Comfortably covers interest (2864.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
10.7x
Attractive valuation — P/E 10.7

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
-1.4
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
8.57%
Healthy income — 8.57% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record
Dividend Growth
+13.3%
Dividend growing fast (13.3% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial